PMID- 32564329 OWN - NLM STAT- MEDLINE DCOM- 20220124 LR - 20220124 IS - 1573-7322 (Electronic) IS - 1382-4147 (Linking) VI - 27 IP - 1 DP - 2022 Jan TI - Arrhythmic risk stratification by cardiac magnetic resonance tissue characterization: disclosing the arrhythmic substrate within the heart muscle. PG - 49-69 LID - 10.1007/s10741-020-09986-0 [doi] AB - Sudden cardiac death (SCD) is a pivotal health problem worldwide. The identification of subjects at increased risk of SCD is crucial for the accurate selection of candidates for implantable cardioverter defibrillator (ICD) therapy. Current strategies for arrhythmic stratification largely rely on left ventricular (LV) ejection fraction (EF), mostly measured by echocardiography, and New York Heart Association functional status for heart failure with reduced EF. For specific diseases, such as hypertrophic and arrhythmogenic cardiomyopathy, some risk scores have been proposed; however, these scores take into account some parameters that are a partial reflection of the global arrhythmic risk and show a suboptimal accuracy. Thanks to a more comprehensive evaluation, cardiac magnetic resonance (CMR) provides insights into the heart muscle (the so-called tissue characterization) identifying cardiac fibrosis as an arrhythmic substrate. Combining sequences before and after administration of contrast media and mapping techniques, CMR is able to characterize the myocardial tissue composition, shedding light on both intracellular and extracellular alterations. Over time, late gadolinium enhancement (LGE) emerged as solid prognostic marker, strongly associated with major arrhythmic events regardless of LVEF, adding incremental value over current strategy in ischemic heart disease and non-ischemic cardiomyopathies. The evidence on a potential prognostic role of mapping imaging is promising. However, mapping techniques require further investigation and standardization. Disclosing the arrhythmic substrate within the myocardium, CMR should be considered as part of a multiparametric approach to personalized arrhythmic stratification. CI - (c) 2020. Springer Science+Business Media, LLC, part of Springer Nature. FAU - Porcari, Aldostefano AU - Porcari A AD - Cardiovascular Department, Division of Cardiology, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Via Pietro Valdoni 7, 34149, Trieste, Italy. FAU - De Luca, Antonio AU - De Luca A AD - Cardiovascular Department, Division of Cardiology, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Via Pietro Valdoni 7, 34149, Trieste, Italy. FAU - Grigoratos, Chrysanthos AU - Grigoratos C AD - Fondazione CNR - Regione Toscana "G. Monasterio", Pisa, Italy. FAU - Biondi, Federico AU - Biondi F AD - Cardiovascular Department, Division of Cardiology, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Via Pietro Valdoni 7, 34149, Trieste, Italy. FAU - Faganello, Giorgio AU - Faganello G AD - Cardiovascular Department, Division of Cardiology, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Via Pietro Valdoni 7, 34149, Trieste, Italy. FAU - Vitrella, Giancarlo AU - Vitrella G AD - Cardiovascular Department, Division of Cardiology, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Via Pietro Valdoni 7, 34149, Trieste, Italy. FAU - Nucifora, Gaetano AU - Nucifora G AD - NorthWest Cardiac Imaging Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK. FAU - Aquaro, Giovanni Donato AU - Aquaro GD AD - Fondazione CNR - Regione Toscana "G. Monasterio", Pisa, Italy. FAU - Merlo, Marco AU - Merlo M AD - Cardiovascular Department, Division of Cardiology, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Via Pietro Valdoni 7, 34149, Trieste, Italy. marco.merlo79@gmail.com. FAU - Sinagra, Gianfranco AU - Sinagra G AD - Cardiovascular Department, Division of Cardiology, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Via Pietro Valdoni 7, 34149, Trieste, Italy. LA - eng PT - Journal Article PT - Review PL - United States TA - Heart Fail Rev JT - Heart failure reviews JID - 9612481 RN - 0 (Contrast Media) RN - AU0V1LM3JT (Gadolinium) SB - IM MH - *Contrast Media MH - Death, Sudden, Cardiac/etiology/prevention & control MH - *Gadolinium MH - Humans MH - Magnetic Resonance Imaging, Cine MH - Magnetic Resonance Spectroscopy MH - Myocardium MH - Predictive Value of Tests MH - Risk Assessment MH - Risk Factors OTO - NOTNLM OT - Arrhythmic stratification OT - Cardiac magnetic resonance OT - Cardiomyopathies OT - Late gadolinium enhancement OT - Mapping imaging OT - Sudden cardiac death EDAT- 2020/06/22 06:00 MHDA- 2022/01/27 06:00 CRDT- 2020/06/22 06:00 PHST- 2020/06/22 06:00 [pubmed] PHST- 2022/01/27 06:00 [medline] PHST- 2020/06/22 06:00 [entrez] AID - 10.1007/s10741-020-09986-0 [pii] AID - 10.1007/s10741-020-09986-0 [doi] PST - ppublish SO - Heart Fail Rev. 2022 Jan;27(1):49-69. doi: 10.1007/s10741-020-09986-0.